An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

BACKGROUND: This study focuses on genetically stratified subgroups of Parkinson’s disease patients (PD) with an enrichment of risk variants in mitochondrial genes,who might benefit from treatment with the “mitochondrial enhancer” coenzyme Q10 (156 mg coenzyme Q10/d [QuinoMit Q10® Fluid] over six mon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurol Res Pract
Egile Nagusiak: Prasuhn, Jannik, Brüggemann, Norbert, Hessler, Nicole, Berg, Daniela, Gasser, Thomas, Brockmann, Kathrin, Olbrich, Denise, Ziegler, Andreas, König, Inke R., Klein, Christine, Kasten, Meike
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Clinical Trial Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650116/
https://ncbi.nlm.nih.gov/pubmed/33324897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-019-0033-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak